Gyre Therapeutics (GYRE) Tax Rate (2010 - 2026)

Gyre Therapeutics (GYRE) has 8 years of Tax Rate data on file, last reported at 6.72% in Q1 2026.

• Quarterly Tax Rate fell 2616.0% year-over-year to 6.72% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 22.43% (up 3292.0% YoY) and the FY2025 annual result came in at 87.77%, down 52853.0% from the prior year.
• Tax Rate declined to 6.72% in Q1 2026 per GYRE's latest filing, from 6.6% in the prior quarter.
• Across five years, Tax Rate topped out at 35.6% in Q2 2023 and bottomed at 22.36% in Q4 2022.
• The 5-year median for Tax Rate is 21.3% (2024), against an average of 14.83%.
• The widest annual swing landed in 2023, when Tax Rate jumped 2166 bps; it then tumbled 2616 bps in 2026.
• Tracing GYRE's Tax Rate over 5 years: stood at 22.36% in 2022, then surged by 97 bps to 0.7% in 2023, then tumbled by 37 bps to 0.96% in 2024, then plunged by 591 bps to 6.6% in 2025, then slipped by 2 bps to 6.72% in 2026.
• Per Business Quant, the three latest GYRE Tax Rate figures stand at 6.72% (Q1 2026), 6.6% (Q4 2025), and 22.19% (Q3 2025).

Peer Comparison